Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.65

€7.65

-2.580%
-0.2
-2.580%
-
 
22:25 / Tradegate WKN: A40ZVN / Name: Viromed Medical / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Viromed Medical AG Stock

A loss of -2.580% shows a downward development for Viromed Medical AG.
So far the community has only identified positive things for Viromed Medical AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Viromed Medical AG in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbHPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbH
EQS-News: Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbH
EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully CompletedPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully Completed
EQS-News: Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully Completed
EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net incomePhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income
EQS-News: Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income